Guardant Health, Inc. (GH)
110.17
+1.43
(+1.32%)
USD |
NASDAQ |
Jan 09, 16:00
110.50
+0.33
(+0.30%)
After-Hours: 04:38
Guardant Health Research and Development Expense (Quarterly): 89.96M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| EXACT Sciences Corp. | 117.22M |
| Illumina, Inc. | 228.00M |
| Natera, Inc. | 173.41M |
| Quest Diagnostics, Inc. | -- |
| GeneDx Holdings Corp. | 19.59M |